Skip to main content

The Future of Psychiatry

As we face unprecedented cases of depression and anxiety worldwide psychiatric providers are having to ask difficult questions about why our current pharmacological interventions aren’t solving the problem. In The Future of Psychiatry, you’ll get answers from two thought leaders…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Keith Kurlander, MA, LPCWill Van Derveer, MD
Learn More

Assessment and Treatment Planning

Providers who are beginning to adopt an integrative approach often ask, “Where do I start?” This course will show you the algorithm of exactly what to do first, second and third from the perspective of an integrative treatment plan. In…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Keith Kurlander, MA, LPCWill Van Derveer, MD
Learn More

Emerging Frameworks in Psychiatry

Psychiatry is overdue for a fresh look at the conditions we diagnose and the treatments we provide. Scott Shannon, MD, a pioneer in the field of integrative psychiatry, reviews emerging frameworks from systems theory to game theory, and cutting-edge technologies…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Scott Shannon, MD
Learn More

Nutritional Psychiatry 101: Food Labels and Sweeteners

It’s all in the label! Right? Well, not so fast. In Nutritional Psychiatry 101, we’ll focus on food labels and sweeteners. We’ll discuss the implication of the FDA’s term: “Daily Values” for mental health. We’ll define FDA nutrient content claim…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Mary Rondeau, ND
Learn More

Nutritional Psychiatry 103: Diet and Mental Health Elimination Diets

Numerous studies confirm that a diet rich in vegetables, fruits, proteins, and whole grains is beneficial. Studies report benefits for patients who suffer from depression, bipolar disease and anxiety. But macronutrient food diversity is only part of the story. Understanding…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Mary Rondeau, ND
Learn More

Nutritional Psychiatry 104: Gluten, Dairy and Yeast

Gluten, dairy, and yeast can have major neuropsychiatric effects. Recent medical research has begun to elucidate the pathophysiology of this connection. Find out how potent the benefits can be when you know how to advise your patients about gluten, dairy,…

Credits: AMA PRA Category 1 Credits™ (1 hour)

Price: $47

Faculty: Mary Rondeau, ND
Learn More

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]